Werbung
Werbung
LAB
Standard BioTools Inc. Common Stock
1.54
USDGesponsert
0.00
+0.32%
09. Jan., 15:55 UTC -5
Geschlossen
Nach-Markt
1.51
-0.03
-2.27%
LAB Ergebnisberichte
Positives Überraschungsverhältnis
LAB übertreffen die 15 der letzten 34Schätzungen.
44%
Nächster Bericht
Datum des nächsten Berichts
24. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$18.68M
/-$0.07
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-4.43%
/-22.22%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-60.00%
/-22.22%
Standard BioTools Inc. Common Stock earnings per share and revenue
On 04. Nov. 2025, LAB reported earnings of -0.09 USD per share (EPS) for Q3 25, missing the estimate of -0.05 USD, resulting in a -61.87% surprise. Revenue reached 19.55 million, compared to an expected 18.18 million, with a 7.56% difference. The market reacted with a -4.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 18.68 million USD, implying an decrease of -22.22% EPS, and decrease of -4.43% in Revenue from the last quarter.
FAQ
What were Standard BioTools Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Standard BioTools Inc. Common Stock reported EPS of -$0.09, missing estimates by -61.87%, and revenue of $19.55M, 7.56% above expectations.
How did the market react to Standard BioTools Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -4.2%, changed from $1.19 before the earnings release to $1.14 the day after.
When is Standard BioTools Inc. Common Stock expected to report next?
The next earning report is scheduled for 24. Feb. 2026.
What are the forecasts for Standard BioTools Inc. Common Stock's next earnings report?
Based on 4
analysts, Standard BioTools Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $18.68M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung